Security key
698955101
Parabilis Medicines, Inc. - Common Stock, $0.0001 par value (PBLS)
CUSIP: 698955101
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 490
- Total 13F value
- $15,364
- Share change
- +490
- SEC-reported price per share
- $32.29
- Number of holders
- 3
- Value change
- +$15,364
- Number of buys
- 3
- Shares outstanding
- 120,995,849
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
3
Top holders
3
PBLS full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
Parabilis Medicines, Inc. SEC filings
Parabilis Medicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 698955101
Recent filing periods:
Ownership snapshot
Top reported holders of PBLS - Parabilis Medicines, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 24%
13D/G row: RA CAPITAL MANAGEMENT, L.P.
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 24%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
24%
FMR LLC
8.5%
ARCH Venture Fund XII, L.P.
5.3%
Soleus Capital Management, L.P.
0.44%
Guy Levy
0.44%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
3/4/5
Company · Director, 10%+ Owner
|
24%
from 13D/G
|
$791,906,364
28,933,371 shares
|
— | 30 Jun 2026 |
| FMR LLC |
13D/G
13F
Company
|
8.5%
|
$304,973,738
10,292,735 shares
|
$0 | 30 Jun 2026 |
| ARCH Venture Fund XII, L.P. |
13D/G
|
5.3%
|
$190,010,671
6,412,780 shares
|
$0 | 30 Jun 2026 |
| Soleus Capital Management, L.P. |
13F
3/4/5
Company · 10%+ Owner
|
0.44%
from 3/4/5
|
$40,098,966
1,465,070 shares
|
— | 30 Jun 2026 |
| Guy Levy |
3/4/5
10%+ Owner
|
0.44%
|
$15,975,492
527,070 shares
|
— | 11 Jun 2026 |
| Soleus Capital Group, LLC |
3/4/5
10%+ Owner
|
0.44%
|
$15,975,492
527,070 shares
|
— | 11 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
490
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
79
Q3 2026 holders
3
Holder diff
-76
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend